Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andreas Helke who wrote (15173)	2/17/1998 11:52:00 AM
From: Henry Niman	Respond to of 32384

Andreas, It's not surprising that LGND is rated a STRONG BUY by Zack's. On Dec 31, Bear Stearns put out new earnings estimates that included a 1999 profit ($0.09). So far they seem to be the only one with numbers for 1999 (listed in reports that came out last week or earlier). I'm pretty certain that Bear Stearns showed a significant loss in earlier estimates. Just over a week ago, LGND showed a major reduction in their 4Q, 1997 loss, and the surprise ranked #1 or #2. Last week Roberston Stephens came out with new earnings estimates. They show an EPS of $0.00 for 1999 (I believe that the projections that they made at the end of 1996 showed a 1999 loss of about $0.65). LGND continues to surprise on the upside, which should help them hold on to the STRONG BUY rating by Zack's.